Best Agrolife Fund Raise of ₹150 Cr

Best Agrolife Management Change

Best Agrolife Limited's board approved the CFO change: Vikas Jain moved to VP Business Operations and Sanjeev Bajaj appointed CFO and KMP. The filing also carries Q2/H1 results, ESOP grant and KMP authorisation details.

Best Agrolife Q2 FY27 Results: Net Profit ₹57.5 Cr, Up 47.8% YoY

Best Agrolife Ltd reported revenue from operations of ₹407.1 Cr (-21.2% YoY) and net profit of ₹57.5 Cr (+47.8% YoY) for Q2 FY27.

Key figure

Net profit ₹57.5 Cr · +47.8% YoY

Best Agrolife Board Meeting Date

Best Agrolife Limited will hold a board meeting on October 30, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.

Best Agrolife Other Announcement

Best Agrolife Ltd has submitted its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ending September 30, 2026.

Best Agrolife Merger & Restructuring Worth ₹0.02 Cr

Best Agrolife Ltd incorporated a new step-down subsidiary, Best Agrolife Do Brazil LTDA, in Brazil. The initial investment for this wholly owned subsidiary is ₹0.02 Crore.

Value

₹0.02 Cr

Best Agrolife Annual General Meeting

Best Agrolife Limited held its 35th Annual General Meeting on September 29, 2026. The meeting transacted ordinary and special business, including financial adoption and dividend declaration.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.